Accéder au contenu
Merck

Acute encephalopathy associated with influenza A virus infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2003-02-21)
Christoph Steininger, Theresia Popow-Kraupp, Hermann Laferl, Andreas Seiser, Irene Gödl, Schiva Djamshidian, Elisabeth Puchhammer-Stöckl
RÉSUMÉ

Twenty-one patients aged 4-78 years with influenza A virus-associated acute encephalopathy were studied. Influenza A virus could be detected only in a cerebrospinal fluid (CSF) specimen obtained from 1 of 18 patients, despite the use of a highly sensitive polymerase chain reaction assay. Six patients experienced influenzal encephalopathy during the course of respiratory illness. Five of these patients had hypoprothrombinemia and 4 had increased serum creatinine levels, indicating hepatic and/or renal dysfunction. Fourteen patients experienced postinfluenzal encephalopathy <or=3 weeks after resolution of acute respiratory symptoms. In 6 patients, focal areas of high signal intensity were visible on T2-weighted magnetic resonance images of the brain. Adenovirus DNA was detected in CSF specimens obtained from 4 (36%) of 11 patients with postinfluenzal encephalopathy. Thus, influenzal encephalopathy is frequently associated with metabolic disorders, whereas postinfluenzal encephalopathy appears to have different possible etiologies.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps anti-grippe A, antigène H-1, clone 58AB7-19-18, clone 58AB7-19-18, Chemicon®, from mouse
Sigma-Aldrich
Anticorps anti-grippe A, antigène H-3, clone 30-2F11-F7-A5, clone 30-2F11-F7-A5, Chemicon®, from mouse